Currently Viewing:
ISPOR 2018
Dr Harlan Krumholz on Barriers Preventing Healthcare From Using Data to Improve Care
August 01, 2018
Dr Clifford Goodman Discusses How Healthcare Should Address Social Determinants of Health
July 20, 2018
Sally Okun on How Informed Patients Feel When Starting Treatment After a New Diagnosis
July 09, 2018
Dr Clifford Goodman on Progress With the Move to Value-Based Payments
July 09, 2018
Dr Adrian F. Hernandez: Mapping Human Health Through Project Baseline
July 03, 2018
Currently Reading
Dr Harlan Krumholz: How Healthcare Can Better Implement New Technologies
June 29, 2018
Sally Okun Outlines What Patients Define as Good Care
June 26, 2018
Dr Adrian F. Hernandez on the Future of Real-World Evidence
June 20, 2018
Dr Harlan Krumholz on Using New Technologies, Data Generation to Prevent or Address Epidemics
June 18, 2018
Sally Okun: Using Digital Health Improvements to Include the Patient Voice in Healthcare
June 14, 2018
Valuation Challenges and Ethical Implications of Cures
May 23, 2018
Value Assessments in the Age of Personalized Medicine May Require a Cultural Shift, Panel Says
May 23, 2018
Dr Ejim Mark: Digital Health Runs the Risk of Exacerbating Disparities
May 23, 2018
Dr Steven Pearson Highlights the Challenge of Evaluating New Interventions That Cure Diseases
May 23, 2018
Panelists Give Payer, Patient, and Economist Perspectives on High-Cost Drugs for Rare Diseases
May 23, 2018
Dr Adrian Hernandez Highlights the Use of Real-World Evidence and Current Barriers
May 22, 2018
Personalizing the Digital Data Revolution in Healthcare
May 22, 2018
All-Cause Healthcare Payments Substantial for Younger Adults With Depression, and Other Poster Findings at ISPOR
May 22, 2018
Dr Clifford Goodman Discusses the Challenge of Valuing New, Expensive Therapies for Rare Diseases
May 22, 2018
Sally Okun: It's Time to Empower the Health Data Being Collected
May 21, 2018
Transforming Healthcare: Boosting Real-World Evidence With Digital Health
May 21, 2018
Value Assessments Are Just One Tool in the Decision-Maker's Toolkit, Panel Says
May 21, 2018
Dr Harlan Krumholz Outlines the Impact of New Technology and Innovations on Healthcare Delivery
May 21, 2018

Dr Harlan Krumholz: How Healthcare Can Better Implement New Technologies

We need to collaborate and test these innovations in controlled circumstances so that we can evaluate their effect and understand what needs to be iterated to continue to improve them, explained Harlan Krumholz, MD, SM, the Harold H. Hines Jr professor, Medicine and Epidemiology and Public Health, Yale School of Medicine, and director, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital.


This page contains sponsored advertising 

We need to collaborate and test these innovations in controlled circumstances so that we can evaluate their effect and understand what needs to be iterated to continue to improve them, explained Harlan Krumholz, MD, SM, the Harold H. Hines Jr professor, Medicine and Epidemiology and Public Health, Yale School of Medicine, and director, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital.

Transcript

It seems like technology is improving at a faster pace than healthcare can keep up; how can we bridge that gap, so healthcare can better implement new technologies? 

Corporations are the key for us to be able to adopt technology at a rapid pace and appropriately. The idea is that we have to all be holding hands collaborating and creating areas in places to test innovation and putting it in controlled circumstances so that we can evaluate their effect and understand what needs to be iterated and continue to improve them. If we don’t work together and create it within safe environments where we’re hyper measuring and understanding their impact, and then being able to scale out when appropriate, we’ll never really make progress because then we’ll just have different vendors and different companies trying to push different solutions and particularly on decision support, all of this needs to be evaluated thoroughly.

But, the problem is that we don’t really have places that are easy for that to be evaluated. We need to create test beds, places these can be tried, but tried in ways that are safe for patients, but still studied intensely so that we can learn from them. Otherwise, there’s a sense that healthcare is resistant to technology. I don’t think that is necessarily the case, I just think we don’t know exactly how to bring it forward. We know how to do that with drugs, we’re doing that with devices, and we could always use more data in those areas. But with regard to technology, we’re just feeling our way about, so when new technology comes out, how should we think about it? Do we think about it like drugs and devices, and if we do, how do we evaluate them quickly in appropriate places so that we can make progress?

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!